Blood product required for the treatment of TTP patients

A Contract Award Notice
by UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST

Source
Contracts Finder
Type
Contract (Products)
Duration
2 year
Value
£98K
Sector
HEALTH
Published
03 Aug 2022
Delivery
01 Jul 2022 to 30 Jun 2024
Deadline
01 Jun 2022 12:00

Concepts

Location

Geochart for 1 buyers and 1 suppliers

1 buyer

1 supplier

Description

Octaplas, blood product required for the treatment of TTP patients. CMU National Framework Agreement for the supply of products for the treatment of Bleeding Disorders including Haemophilia B Offer reference number: CM/PHS/19/5576

Award Detail

1 Octapharma (Manchester)
  • Value: £97,500

CPV Codes

  • 33141510 - Blood products

Reference

Domains